Steve De Vos

5PUBLICATIONS
22CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineProteins and peptidesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 Inhibitor.

Hans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx

|May 28, 2024
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.

Oscar Mammoliti, Sébastien Martina, Pieter Claes

|Mar 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.

Christophe Peixoto, Agnes Joncour, Taouès Temal-Laib

|Dec 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.

Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy

|Feb 15, 2023
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.

Stéphanie Lavazais, Manja Jargosch, Sonia Dupont

Pageof 1

Frequent Collaborators

3 joint publications

Nicolas Desroy

2 joint publications

Line Oste

1 joint publications

Stéphanie Lavazais

1 joint publications

Catherine Jagerschmidt